Healthcare IT Today July 29, 2022
Oncoustics’ SaMD Works on Any Ultrasound System Making AI-Driven Diagnostics, Surveillance and Treatment Monitoring Available and Accessible at Point of Care
Oncoustics (http://www.oncoustics.com), the leader in ultrasound-based tissue characterization solutions announces the initial close of a $5 million+ seed round of funding to advance its SaMD (software as a medical device) technology for the low-cost assessment of structural diseases at point of care. Oncoustics’ first products will focus on liver disease, one of the fastest-growing causes of morbidity and mortality in the world. The round is co-led by Creative Ventures and Saltagen Ventures.
Other investors in the round include NorthSpring Capital Partners, Fraser Kearney Capital Corp., Pallasite Ventures, and Dr. Chen Fong, a renowned radiologist, entrepreneur/investor and inductee into the...